UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 325

Sortiert nach

Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective

Clinical drug investigation, 2022-09, Vol.42 (9), p.733-746

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness Analysis of CYP2D610 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Clinical drug investigation, 2020, Vol.40 (1), p.25-32

2020

Link zum Volltext

Verfügbarkeit prüfen

Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis

Clinical drug investigation, 2019-01, Vol.39 (1), p.15-26

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab

Clinical drug investigation, 2019-12, Vol.39 (12), p.1205-1212

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone: A Randomized, Three-Phase, Crossover, Placebo-Controlled Study

Clinical drug investigation, 2011-01, Vol.31 (3), p.143-153

2011

Link zum Volltext

Verfügbarkeit prüfen

Multiple Sclerosis Relapses Following Cessation of Fingolimod

Clinical drug investigation, 2022-04, Vol.42 (4), p.355-364

2022

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada

Clinical drug investigation, 2018-05, Vol.38 (5), p.449-455

2018

Link zum Volltext

Verfügbarkeit prüfen

Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods

Clinical drug investigation, 2014-08, Vol.34 (8), p.593-598

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV

Clinical drug investigation, 2010-01, Vol.30 (6), p.405-411

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Evaluation of Glucose Homeostasis in a Cohort of HAART-Treated HIV-Infected Children: A Longitudinal, Observational Cohort Study

Clinical drug investigation, 2009-01, Vol.29 (2), p.101-109

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations

Clinical drug investigation, 2020-11, Vol.40 (11), p.1063-1070

2020

Link zum Volltext

Verfügbarkeit prüfen

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review

Clinical drug investigation, 2018-08, Vol.38 (8), p.653-671

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan

Clinical drug investigation, 2023-11, Vol.43 (11), p.839-850

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab

Clinical drug investigation, 2018-09, Vol.38 (9), p.873-880

2018

Link zum Volltext

Verfügbarkeit prüfen

Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data

Clinical drug investigation, 2020-12, Vol.40 (12), p.1147-1154

2020

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients

Clinical drug investigation, 2022-02, Vol.42 (2), p.185-192

2022

Link zum Volltext

Verfügbarkeit prüfen

West Syndrome: A Review and Guide for Paediatricians

Clinical drug investigation, 2018-02, Vol.38 (2), p.113-124

2018

Link zum Volltext

Verfügbarkeit prüfen

Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches

Clinical drug investigation, 2024-02, Vol.44 (2), p.91-108

Lipton, Jeffrey H.

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Therapeutic Efficacy of a Fixed Low-Dose Combination of Cinnarizine and Dimenhydrinate with Betahistine in Vestibular Neuritis: A Randomized, Double-Blind, Non-Inferiority Study

Clinical drug investigation, 2012-06, Vol.32 (6), p.387-399

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights

Clinical drug investigation, 2013-09, Vol.33 (9), p.621-631

2013

Link zum Volltext

Verfügbarkeit prüfen

Riboflavin in Neurological Diseases: A Narrative Review

Clinical drug investigation, 2021-06, Vol.41 (6), p.513-527

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects

Clinical drug investigation, 2020-06, Vol.40 (6), p.529-540

2020

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report

Clinical drug investigation, 2019-10, Vol.39 (10), p.1003-1007

Pan, Janet

2019

Link zum Volltext

Verfügbarkeit prüfen

A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults

Clinical drug investigation, 2015-10, Vol.35 (10), p.633-643

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 325

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Physics: Conference Series

KollektionPublisher or Other Site

Zeitschrift / SerieClinical Drug Investigation

ThemaInternal Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(325)

Publikationsform

Artikel
(325)

Sprache

Englisch
(325)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nexis Uni
(325)
Publisher site
(325)
SpringerLink (Online service)
(325)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(324)
MEDLINE
(266)

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective

Cost-effectiveness Analysis of CYP2D610 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis

Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab

Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone: A Randomized, Three-Phase, Crossover, Placebo-Controlled Study

Multiple Sclerosis Relapses Following Cessation of Fingolimod

Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada

Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods

Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects

Long-Term Evaluation of Glucose Homeostasis in a Cohort of HAART-Treated HIV-Infected Children: A Longitudinal, Observational Cohort Study

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review

Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan

Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab

Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data

Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients

West Syndrome: A Review and Guide for Paediatricians

Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches

Comparison of the Therapeutic Efficacy of a Fixed Low-Dose Combination of Cinnarizine and Dimenhydrinate with Betahistine in Vestibular Neuritis: A Randomized, Double-Blind, Non-Inferiority Study

Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights

Riboflavin in Neurological Diseases: A Narrative Review

Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects

Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report

A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults

Aktive Filter

Suchergebnisse filtern